New-generation oral anticoagulants carry a lower risk of intracranial haemorrhage (ICH) than does warfarin, a new systematic review and meta-analysis shows. Chatterjee et al. analysed six studies, which had recruited a total of 57,491 patients with atrial fibrillation who received anticoagulants for stroke prevention. All novel anticoagulants, which interact directly with coagulating proteins, were associated with a 50% reduced risk of ICH compared with warfarin-based vitamin K antagonists.
ORIGINAL RESEARCH PAPER
Chatterjee, S. et al. New oral anticoagulants and the risk of intracranial hemorrhage. JAMA Neurol. doi:10.1001/jamaneurol.2013.4021
Rights and permissions
About this article
Cite this article
Novel oral anticoagulants for stroke prevention are associated with reduced risk of intracranial haemorrhage. Nat Rev Neurol 9, 659 (2013). https://doi.org/10.1038/nrneurol.2013.239
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2013.239